$3.9M grant for work on anti-addiction drug
The National Institute on Drug Abuse gives a Louisiana researcher $3.9 million to keep working on a
potential drug to treat cocaine addiction, and to begin tests on people.
That word is from Embera NeuroTherapeutics, Inc., which has LSU's license to develop the drug worked up by Nicholas Goeders of the LSU Health Sciences Center-Shreveport.
Goeders is both head of the medical school's pharmacology department and Embera's chief scientific officer.
The drug combines two already on the market - the tranquilizer oxazepam and metyrapone, which
reduces a body's ability to pump out the stress hormone cortisol.
Goeders says preliminary tests indicate the drug might also help people stop smoking.
The vast majority of tested drugs never make it to market.